[1]
2022. Pathophysiology And Management Of Sickle Cell Disease: New Therapeutic Approaches And Disease-Modifying Treatments. Journal of Pharmaceutical Negative Results. 13, 4 (Oct. 2022), 2305–2310. DOI:https://doi.org/10.47750/ceg2qf48.